Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daneshmand

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Favorable long-term Health Related Quality of Life in cured survivors of testicular cancer management. So, what now?A D'Souza, J King, L Nappi, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 6, 2005
Targeted mid-trimester ultrasound examination: how does fetal anatomic visualization depend upon the duration of the scan?V Catanzarite, K Delaney, S Wolfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatmentK M Wymer, S Daneshmand, P M Pierorazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacyC Kollmannsberger, C Moore, K N Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapiesC Kollmannsberger, S Tyldesley, C Moore, et al.
Human Genetics|June 1, 1994
Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein lociX Bu, C H Warden, Y R Xia, et al.
The Journal of Urology|October 26, 2019
Reply by AuthorsY Lotan, B A Inman, L G Davis, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancerJ W F Catto, B Tran, M RouprĂȘt, et al.
British Journal of Cancer|November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counsellingE Xylinas, E K Cha, M Sun, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Favorable long-term Health Related Quality of Life in cured survivors of testicular cancer management. So, what now?A D'Souza, J King, L Nappi, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 6, 2005
Targeted mid-trimester ultrasound examination: how does fetal anatomic visualization depend upon the duration of the scan?V Catanzarite, K Delaney, S Wolfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2017
Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatmentK M Wymer, S Daneshmand, P M Pierorazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacyC Kollmannsberger, C Moore, K N Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapiesC Kollmannsberger, S Tyldesley, C Moore, et al.
Human Genetics|June 1, 1994
Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein lociX Bu, C H Warden, Y R Xia, et al.
The Journal of Urology|October 26, 2019
Reply by AuthorsY Lotan, B A Inman, L G Davis, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancerJ W F Catto, B Tran, M RouprĂȘt, et al.
British Journal of Cancer|November 22, 2012
Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counsellingE Xylinas, E K Cha, M Sun, et al.
Pageof 3